Log in

ATAGI recommendation for COVID Vaccination in immunocompromised patients

8 Oct 2021 4:52 PM | Anonymous member (Administrator)

Dear Colleagues, re: The ATAGI recommendation for COVID Vaccination in immunocompromised patients

This is an important recommendation from ATAGI and is relevant to many patients with haematological disorders who may have reduced response to standard COVID vaccination regimens. 
Steven Lane, President HSANZ

Click here for document


CONTACT

Haematology Society of Australia and New Zealand (HSANZ)
145 Macquarie Street, Sydney NSW 2000
Tel: 02 8097 8114


FOLLOW US

Copyright © 2020 Haematology Society of Australia & New Zealand (HSANZ). All Rights Reserved.

Powered by Wild Apricot Membership Software